Cln3em1Dprc
Endonuclease-mediated Allele Detail
|
Symbol: |
Cln3em1Dprc |
Name: |
CLN3 lysosomal/endosomal transmembrane protein, battenin; endonuclease-mediated mutation 1, David Pearce |
MGI ID: |
MGI:6474168 |
Synonyms: |
Cln3Q352X |
Gene: |
Cln3 Location: Chr7:126170571-126184991 bp, - strand Genetic Position: Chr7, 69.16 cM
|
Alliance: |
Cln3em1Dprc page
|
|
|
Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
Mutation: |
|
Single point mutation
|
|
|
Mutation details: CRISPR/Cas9 technology introduced a C to T nonsense mutation at position 1054 (c.1054C>T) in exon 16 causing glutamine 352 to be replaced with a premature stop codon (Q352X). Homozygous mice show reduced transcript levels in various tissues.
(J:294634)
|
|
|
Key: |
hm |
homozygous |
ht |
heterozygous |
tg |
involves transgenes |
√ |
phenotype observed |
cn |
conditional genotype |
cx |
complex: > 1 genome feature |
ot |
other: hemizygous, indeterminate,... |
N |
normal phenotype |
|
Genotype/ Background: |
| Allelic Composition | Genetic Background | Cell Line(s) |
---|
Loading... | | | | |
|
Phenotypes: |
Affected Systems |
|
|
behavior/neurological
|
√
|
impaired coordination
|
√
|
cellular
|
√
|
abnormal lysosome morphology
|
√
|
growth/size/body
|
√
|
decreased body weight
|
√
|
hematopoietic system
|
√
|
increased microglial cell activation
|
√
|
homeostasis/metabolism
|
√
|
abnormal enzyme/coenzyme activity
|
√
|
immune system
|
√
|
increased microglial cell activation
|
√
|
nervous system
|
√
|
increased microglial cell activation
|
√
|
abnormal astrocyte morphology
|
√
|
astrocytosis
|
√
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Cln3 Mutation: |
38 strains or lines available
|
|
Original: |
J:294634 Langin L, et al., A tailored Cln3(Q352X) mouse model for testing therapeutic interventions in CLN3 Batten disease. Sci Rep. 2020 Jun 29;10(1):10591 |
All: |
1 reference(s) |
|